" The White House says Barron Trump is 'too tall' at 6'9" to serve in the military. David Robinson was 7'0" and put his NBA ...

Coach Kendrick Warren and the entire team want that state championship. The win over Strasburg on Tuesday was just the start.

Most people don’t set out to ignore their health. It usually slips down the list somewhere between the morning alarm and the ...

The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with idiopathic short stature, short stature born small for gestational age, or ...

This once-weekly C-type natriuretic peptide analog functions by antagonizing overactive FGFR3 signaling to improve growth in pediatric patients.

Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published ...

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Investing.com -- Novo Nordisk announced late Friday that the US Food and Drug Administration has approved three new indications for once-weekly Sogroya (somapacitan-beco) injection 5 mg, 10 mg, or 15 ...